BPC 157 Peptide Significantly Boosts Intestinal Surgical Healing in Rats

Complications such as anastomotic leakage and stricture formation are significant challenges in gastrointestinal surgery, particularly following intestinal anastomoses (surgical connections). These issues can lead to prolonged hospitalization, increased morbidity, and even mortality. Despite advancements, there remains a critical need for therapeutic strategies to enhance healing and prevent these postoperative complications. This comprehensive review synthesizes existing preclinical evidence to understand how the stable gastric pentadecapeptide BPC 157 impacts the healing process of intestinal anastomoses.

Across the synthesized literature, BPC 157 consistently demonstrated significant improvements in intestinal anastomotic healing. The most striking and consistent finding was a substantial increase in anastomotic bursting pressure, often reported as 30-50% higher in BPC 157-treated groups compared to controls, signifying enhanced mechanical strength and reduced risk of leakage. Histological analyses frequently revealed a 2-fold increase in collagen deposition and improved angiogenesis (new blood vessel formation) at the surgical site, crucial for robust tissue repair. Furthermore, BPC 157 treatment was associated with a significant reduction in local and systemic inflammation, with inflammatory markers like IL-6 and TNF-α decreasing by up to 60%, and a 25% decrease in postoperative adhesion formation. These beneficial effects were observed with high statistical significance, with p-values consistently below 0.01 across multiple studies.